Annual CFF
$154.42 M
+$59.63 M+62.92%
December 31, 2024
Summary
- As of March 12, 2025, KURA annual cash flow from financing activities is $154.42 million, with the most recent change of +$59.63 million (+62.92%) on December 31, 2024.
- During the last 3 years, KURA annual CFF has risen by +$157.85 million (+4595.40%).
- KURA annual CFF is now -67.10% below its all-time high of $469.33 million, reached on December 31, 2020.
Performance
KURA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$806.00 K
-$1.40 M-63.40%
December 31, 2024
Summary
- As of March 12, 2025, KURA quarterly cash flow from financing activities is $806.00 thousand, with the most recent change of -$1.40 million (-63.40%) on December 31, 2024.
- Over the past year, KURA quarterly CFF has increased by +$115.00 thousand (+16.64%).
- KURA quarterly CFF is now -99.75% below its all-time high of $327.04 million, reached on December 31, 2020.
Performance
KURA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$154.42 M
+$115.00 K+0.07%
December 31, 2024
Summary
- As of March 12, 2025, KURA TTM cash flow from financing activities is $154.42 million, with the most recent change of +$115.00 thousand (+0.07%) on December 31, 2024.
- Over the past year, KURA TTM CFF has increased by +$59.63 million (+62.92%).
- KURA TTM CFF is now -67.10% below its all-time high of $469.33 million, reached on December 31, 2020.
Performance
KURA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KURA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.9% | +16.6% | +62.9% |
| 3 y3 years | +4595.4% | +16.6% | +62.9% |
| 5 y5 years | +39.0% | +16.6% | +62.9% |
KURA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4595.4% | -99.5% | -100.0% | -36.5% | +4595.4% |
| 5 y | 5-year | -67.1% | +4595.4% | -99.8% | +112.3% | -67.1% | +4595.4% |
| alltime | all time | -67.1% | +4595.4% | -99.8% | +112.3% | -67.1% | +4595.4% |
Kura Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $154.42 M(+62.9%) | $806.00 K(-63.4%) | $154.42 M(+0.1%) |
| Sep 2024 | - | $2.20 M(-27.6%) | $154.30 M(+1.4%) |
| Jun 2024 | - | $3.04 M(-98.0%) | $152.18 M(-37.4%) |
| Mar 2024 | - | $148.37 M(>+9900.0%) | $243.15 M(+156.5%) |
| Dec 2023 | $94.78 M(+145.8%) | $691.00 K(+722.6%) | $94.78 M(-26.4%) |
| Sep 2023 | - | $84.00 K(-99.9%) | $128.81 M(-0.6%) |
| Jun 2023 | - | $94.01 M(>+9900.0%) | $129.60 M(+238.7%) |
| Mar 2023 | - | $0.00(-100.0%) | $38.26 M(-0.8%) |
| Dec 2022 | $38.56 M(-1222.7%) | $34.71 M(+3844.7%) | $38.56 M(+730.1%) |
| Sep 2022 | - | $880.00 K(-67.0%) | $4.65 M(-22.9%) |
| Jun 2022 | - | $2.67 M(+780.9%) | $6.02 M(-287.6%) |
| Mar 2022 | - | $303.00 K(-61.8%) | -$3.21 M(-6.5%) |
| Dec 2021 | -$3.44 M(-100.7%) | $794.00 K(-64.8%) | -$3.44 M(-101.1%) |
| Sep 2021 | - | $2.26 M(-134.4%) | $322.81 M(-0.7%) |
| Jun 2021 | - | -$6.57 M(-8411.4%) | $325.23 M(-30.7%) |
| Mar 2021 | - | $79.00 K(-100.0%) | $469.17 M(-0.0%) |
| Dec 2020 | $469.33 M(+322.4%) | $327.04 M(+6883.5%) | $469.33 M(+228.5%) |
| Sep 2020 | - | $4.68 M(-96.6%) | $142.88 M(+3.0%) |
| Jun 2020 | - | $137.37 M(>+9900.0%) | $138.76 M(+24.7%) |
| Mar 2020 | - | $247.00 K(-57.6%) | $111.25 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $111.10 M(-16.2%) | $583.00 K(+4.3%) | $111.10 M(-0.5%) |
| Sep 2019 | - | $559.00 K(-99.5%) | $111.66 M(-39.7%) |
| Jun 2019 | - | $109.86 M(>+9900.0%) | $185.07 M(+146.5%) |
| Mar 2019 | - | $102.00 K(-91.1%) | $75.09 M(-43.4%) |
| Dec 2018 | $132.64 M(+147.6%) | $1.14 M(-98.5%) | $132.64 M(+1.1%) |
| Sep 2018 | - | $73.97 M(<-9900.0%) | $131.16 M(+18.3%) |
| Jun 2018 | - | -$125.00 K(-100.2%) | $110.90 M(-0.3%) |
| Mar 2018 | - | $57.65 M(<-9900.0%) | $111.21 M(+107.6%) |
| Dec 2017 | $53.57 M(+618.7%) | -$338.00 K(-100.6%) | $53.57 M(-0.6%) |
| Sep 2017 | - | $53.71 M(>+9900.0%) | $53.91 M(>+9900.0%) |
| Jun 2017 | - | $189.00 K(+3680.0%) | $194.00 K(-97.4%) |
| Mar 2017 | - | $5000.00(>+9900.0%) | $7.46 M(+0.1%) |
| Dec 2016 | $7.45 M(-92.8%) | $0.00(0.0%) | $7.45 M(-87.1%) |
| Sep 2016 | - | $0.00(-100.0%) | $57.73 M(+0.4%) |
| Jun 2016 | - | $7.45 M(>+9900.0%) | $57.48 M(+24.2%) |
| Mar 2016 | - | $0.00(-100.0%) | $46.29 M(-55.0%) |
| Dec 2015 | $102.87 M | $50.28 M(<-9900.0%) | $102.87 M(+95.6%) |
| Sep 2015 | - | -$252.00 K(-93.3%) | $52.59 M(-0.5%) |
| Jun 2015 | - | -$3.74 M(-106.6%) | $52.84 M(-6.6%) |
| Mar 2015 | - | $56.58 M | $56.58 M |
FAQ
- What is Kura Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Kura Oncology?
- What is Kura Oncology annual CFF year-on-year change?
- What is Kura Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kura Oncology?
- What is Kura Oncology quarterly CFF year-on-year change?
- What is Kura Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kura Oncology?
- What is Kura Oncology TTM CFF year-on-year change?
What is Kura Oncology annual cash flow from financing activities?
The current annual CFF of KURA is $154.42 M
What is the all time high annual CFF for Kura Oncology?
Kura Oncology all-time high annual cash flow from financing activities is $469.33 M
What is Kura Oncology annual CFF year-on-year change?
Over the past year, KURA annual cash flow from financing activities has changed by +$59.63 M (+62.92%)
What is Kura Oncology quarterly cash flow from financing activities?
The current quarterly CFF of KURA is $806.00 K
What is the all time high quarterly CFF for Kura Oncology?
Kura Oncology all-time high quarterly cash flow from financing activities is $327.04 M
What is Kura Oncology quarterly CFF year-on-year change?
Over the past year, KURA quarterly cash flow from financing activities has changed by +$115.00 K (+16.64%)
What is Kura Oncology TTM cash flow from financing activities?
The current TTM CFF of KURA is $154.42 M
What is the all time high TTM CFF for Kura Oncology?
Kura Oncology all-time high TTM cash flow from financing activities is $469.33 M
What is Kura Oncology TTM CFF year-on-year change?
Over the past year, KURA TTM cash flow from financing activities has changed by +$59.63 M (+62.92%)